-
1
-
-
0025764541
-
Cardiac sources of embolism and cerebral infarction. Clinical consequences and vascular concomitants: The Lausanne Stroke Registry
-
Bougousslavsky J, Cachin C, Regli F, Des-pland PA, Van Melle G, Kappenberger L: Cardiac sources of embolism and cerebral infarction. Clinical consequences and vascular concomitants: The Lausanne Stroke Registry. Neurolog y 1991; 41: 855-959.
-
(1991)
Neurolog y
, vol.41
, pp. 855-959
-
-
Bougousslavsky, J.1
Cachin, C.2
Regli, F.3
Des-pland, P.A.4
Van Melle, G.5
Kappenberger, L.6
-
2
-
-
0024380805
-
Cardiogenic brain embolism
-
Cerebral Embolism Task Force
-
Cerebral Embolism Task Force: Cardiogenic brain embolism. Arch Neurol 1989; 46: 727-743.
-
(1989)
Arch Neurol
, vol.46
, pp. 727-743
-
-
-
3
-
-
0027417710
-
Brain infarction severity according to cardiac or arterial embolic source
-
Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, et al: Brain infarction severity according to cardiac or arterial embolic source. Neurology 1993; 43: 728-733.
-
(1993)
Neurology
, vol.43
, pp. 728-733
-
-
Timsit, S.G.1
Sacco, R.L.2
Mohr, J.P.3
Foulkes, M.A.4
Tatemichi, T.K.5
Wolf, P.A.6
-
5
-
-
0035134761
-
Epidemiology and natural history of atrial fibrillation: Clinical implication
-
Chugh SS, Blackshear JL, Win-Kuang S, Hemmill SC, Gersh BJ: Epidemiology and natural history of atrial fibrillation: clinical implication. J Am Coll Cardiol 2001; 37:371-378.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 371-378
-
-
Chugh, S.S.1
Blackshear, J.L.2
Win-Kuang, S.3
Hemmill, S.C.4
Gersh, B.J.5
-
6
-
-
64149122764
-
Cavidades izquierdas
-
ed, Ecocardiografía. Madrid, Edicomplet
-
Rodriguez Padial L: Cavidades izquierdas; in Rodriguez Padial L (ed): Ecocardiografía. Madrid, Edicomplet, 2006, pp 121-144.
-
(2006)
Rodriguez Padial L
, pp. 121-144
-
-
Rodriguez Padial, L.1
-
7
-
-
85120091953
-
-
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al: ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation - Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48:854-906.
-
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al: ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation - Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48:854-906.
-
-
-
-
8
-
-
41949101550
-
-
Ruiz M, Romo E, Mesa D, Delgado M, An-guita M, López A, et al: Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS2 en una población mediterránea. Rev Esp Cardiol 20 08; 61: 29-35.
-
Ruiz M, Romo E, Mesa D, Delgado M, An-guita M, López A, et al: Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS2 en una población mediterránea. Rev Esp Cardiol 20 08; 61: 29-35.
-
-
-
-
9
-
-
39149084073
-
ATRIA Study Group: Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
-
Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE; ATRIA Study Group: Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008; 51: 810-815.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 810-815
-
-
Fang, M.C.1
Go, A.S.2
Chang, Y.3
Borowsky, L.4
Pomernacki, N.K.5
Singer, D.E.6
-
10
-
-
33947307931
-
SPORTIF Investigators: Effect of hypertension on anticoag-ulated patients with atrial fibrillation
-
Lip GY, Frison L, Grind M; SPORTIF Investigators: Effect of hypertension on anticoag-ulated patients with atrial fibrillation. Eur Heart J 2007; 28:752-759.
-
(2007)
Eur Heart J
, vol.28
, pp. 752-759
-
-
Lip, G.Y.1
Frison, L.2
Grind, M.3
-
11
-
-
20044369896
-
-
Wachtell K, Letho M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End point in hypertension (LIFE) study. J Am Coll Cardiol 20 05; 45: 712-719.
-
Wachtell K, Letho M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End point in hypertension (LIFE) study. J Am Coll Cardiol 20 05; 45: 712-719.
-
-
-
-
12
-
-
20444477986
-
AFFIRM Investigators: Are transthoracic echocardio-graphic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
-
Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, et al; AFFIRM Investigators: Are transthoracic echocardio-graphic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 2005; 45:2026-2033.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 2026-2033
-
-
Olshansky, B.1
Heller, E.N.2
Mitchell, L.B.3
Chandler, M.4
Slater, W.5
Green, M.6
-
13
-
-
11144263977
-
Atrial fibrillation: A perspective: thinking inside and outside the box
-
Wyse DG, Gersh BJ: Atrial fibrillation: a perspective: thinking inside and outside the box. Circulation 2004; 109:3089-3095.
-
(2004)
Circulation
, vol.109
, pp. 3089-3095
-
-
Wyse, D.G.1
Gersh, B.J.2
-
14
-
-
3042565157
-
Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation
-
Dernellis J, Panaretou M: Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004; 25: 1100-1107.
-
(2004)
Eur Heart J
, vol.25
, pp. 1100-1107
-
-
Dernellis, J.1
Panaretou, M.2
-
15
-
-
0344861847
-
Anticoagula-tion therapy for stroke prevention in atrial fibrillation: How well randomized trials translate into clinical practice?
-
Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, et al: Anticoagula-tion therapy for stroke prevention in atrial fibrillation: how well randomized trials translate into clinical practice? JAMA 2003; 290: 2685-2692.
-
(2003)
JAMA
, vol.290
, pp. 2685-2692
-
-
Go, A.S.1
Hylek, E.M.2
Chang, Y.3
Phillips, K.A.4
Henault, L.E.5
Capra, A.M.6
-
16
-
-
0037028022
-
A comparison of rate control and rhythm control in patients with atrial fibrillation
-
The AFFIRM Investigators
-
The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
-
(2002)
N Engl J Med
, vol.347
, pp. 1825-1833
-
-
-
17
-
-
1842434297
-
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
-
The AFFIRM Investigators
-
The AFFIRM Investigators: Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004; 109: 1509-1513.
-
(2004)
Circulation
, vol.109
, pp. 1509-1513
-
-
-
18
-
-
33947323278
-
RACE Investigators: Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial f ibrillation in hypertensives: data of the RACE study
-
Rienstra M, Van Veldhuisen DJ, Crijns HJG, Van Gelder IC; RACE Investigators: Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial f ibrillation in hypertensives: data of the RACE study. Eur Heart J 2007; 28: 741-751.
-
(2007)
Eur Heart J
, vol.28
, pp. 741-751
-
-
Rienstra, M.1
Van Veldhuisen, D.J.2
Crijns, H.J.G.3
Van Gelder, I.C.4
-
19
-
-
20544432236
-
Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation
-
Falk RH: Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation. Circulation 2005; 11 : 3141-3157.
-
(2005)
Circulation
, vol.11
, pp. 3141-3157
-
-
Falk, R.H.1
-
20
-
-
33748087086
-
Prospective randomized study comparing amiodarone vs. amiodarone plus losar-tan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
-
Yin Y, Dalal D, Liu Z, Wu J, Liu D, Lan X, et al: Prospective randomized study comparing amiodarone vs. amiodarone plus losar-tan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. Eur Heart J 2006; 27: 1841-1846.
-
(2006)
Eur Heart J
, vol.27
, pp. 1841-1846
-
-
Yin, Y.1
Dalal, D.2
Liu, Z.3
Wu, J.4
Liu, D.5
Lan, X.6
-
21
-
-
20344396863
-
Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis
-
Healy JS, Baranchuck A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al: Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832-1839.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1832-1839
-
-
Healy, J.S.1
Baranchuck, A.2
Crystal, E.3
Morillo, C.A.4
Garfinkle, M.5
Yusuf, S.6
-
22
-
-
1842295207
-
-
Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al: Ventricular dysfunction and the risk of stroke after myo-cardial infa rction. N Eng l J Med 1997; 336: 251-257.
-
Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al: Ventricular dysfunction and the risk of stroke after myo-cardial infa rction. N Eng l J Med 1997; 336: 251-257.
-
-
-
-
23
-
-
0033545829
-
Stroke in patients with acute coronary syndromes: Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integri-lin therapy (PURSUIT) trial
-
Mahaffey KW, Harrington RA, Simoons ML, Granger CB, Graffagnino C, Alberts MJ, et al: Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integri-lin therapy (PURSUIT) trial. Circulation 1999; 99:2371-2377.
-
(1999)
Circulation
, vol.99
, pp. 2371-2377
-
-
Mahaffey, K.W.1
Harrington, R.A.2
Simoons, M.L.3
Granger, C.B.4
Graffagnino, C.5
Alberts, M.J.6
|